|
|
Volumn 148, Issue 6, 2012, Pages 1079-1080
|
|
Redefining clinical trials: The age of personalized medicine
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
BIOLOGICAL MARKER;
CRIZOTINIB;
ARTICLE;
CANCER THERAPY;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG EFFICACY;
DRUG POTENCY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
LUNG CANCER;
PERSONALIZED MEDICINE;
PRIORITY JOURNAL;
STUDY DESIGN;
|
|
EID: 84858396530
PISSN: 00928674
EISSN: 10974172
Source Type: Journal
DOI: 10.1016/j.cell.2012.02.041 Document Type: Note |
|
Times cited : (28)
|
|
References (0)
|
